2000 APR 13 - (NewsRx.com) --
Haemacure Corporation announced that a manufacturing agreement reached in 1999 with Bio Products Laboratory (BPL) has received British government approval.
The agreement calls for BPL to manufacture Haemacure's fibrin sealant products - Hemaseel APR and a frozen formula version of that product. Located just outside of London, in Elstree, United Kingdom, BPL is an agency of the National Blood Authority - National Health Agency (NHA).
In Fall 1999, Haemacure began ordering equipment, and the parties began work on plant layouts and with Immuno …

Комментариев нет:
Отправить комментарий